Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biohit Oyj B

BIOBV
Current price
2.45 EUR +0.02 EUR (+0.82%)
Last closed 2.37 EUR
ISIN FI0009005482
Sector Healthcare
Industry Biotechnology
Exchange Helsinki Exchange
Capitalization 37 214 841 EUR
Yield for 12 month +27.27 %
1Y
3Y
5Y
10Y
15Y
BIOBV
21.11.2021 - 28.11.2021

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company's diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for determination of vitamin D status; and Biohit Calprotectin test for measuring human calprotectin. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H. Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H. pylori infection; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen. In addition, the company provides acetaldehyde-binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. The company was incorporated in 1988 and is headquartered in Helsinki, Finland. Address: Laippatie 1, Helsinki, Finland, 00880

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.56 EUR

P/E ratio

22.0909

Dividend Yield

Current Year

+13 190 682 EUR

Last Year

+11 047 045 EUR

Current Quarter

+6 557 008 EUR

Last Quarter

Current Year

+8 356 654 EUR

Last Year

+7 173 366 EUR

Current Quarter

+4 539 467 EUR

Last Quarter

Key Figures BIOBV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 849 076 EUR
Operating Margin TTM 17.57 %
PE Ratio 22.0909
Return On Assets TTM 8.08 %
PEG Ratio
Return On Equity TTM 16.68 %
Wall Street Target Price 2.56 EUR
Revenue TTM 14 098 576 EUR
Book Value 0.72 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 13.8 %
Dividend Yield
Gross Profit TTM 7 174 375 EUR
Earnings per share 0.11 EUR
Diluted Eps TTM 0.11 EUR
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY -12 %
Profit Margin 11.81 %

Dividend Analytics BIOBV

Dividend growth over 5 years

Continuous growth

2 years

Payout Ratio 5 years average

Dividend History BIOBV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 15.04.2014
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BIOBV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 22.0909
Forward PE
Enterprise Value Revenue 2.3319
Price Sales TTM 2.6396
Enterprise Value EBITDA 18.0261
Price Book MRQ 3.4159

Financials BIOBV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIOBV

For 52 weeks

1.82 EUR 2.67 EUR
50 Day MA 2.3 EUR
Shares Short Prior Month
200 Day MA 2.12 EUR
Short Ratio
Shares Short
Short Percent